drugset / Trial / NCT01045798

Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)

NCT01045798 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a pilot feasibility study that investigates antifungal therapy with caspofungin in patients at high-risk for developing invasive candidiasis in a critical care setting.

Timeline

Start
2010-12
Primary completion
2012-04
Completion
2012-04

Outcome

Outcome not reported

Stopped (Enrollment): “Low participant enrollment: 15 enrolled of 114 planned”

Drugs

EvaluationDrugModalityDoseRoute
Subject Caspofungin Other / unclassified 50 mg Intravenous

Indications